Lineage Cell Therapeutics Inc (LCTX) - Financial and Strategic SWOT Analysis Review

July 2021 | 53 pages | ID: B27A25ECED6EN
GlobalData

Abstracts

Lineage Cell Therapeutics Inc (LCTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lineage Cell Therapeutics Inc (Lineage) formerly known as BioTime Inc, is a clinical-stage biotechnology company that develops new cell therapies for unmet medical needs. It develops products based on its core proprietary technology cell-based therapy platform. The company focuses on developing new cellular therapies for neurological conditions associated with demyelination and degenerative retinal diseases. The company lead product Renevia is developed for the treatment of facial lipoatrophy and HIV lipoatrophy. Its pipeline products include OpRegen for advanced dry age-related macular degeneration, Opc1 in acute spinal cord injury, and Vac2 for non-small cell lung cancer. The company has subsidiaries in Israel, Singapore and the US. Lineage is headquartered in Carlsbad, California, the US.

Lineage Cell Therapeutics Inc Key Recent Developments

Jun 16,2021: Lineage Cell Therapeutics Announces Kevin L. Cook to Join as Chief Financial Officer
Jun 15,2021: Lineage Cell Therapeutics to Present at Raymond James 2021 Human Health Innovation Conference on June 22, 2021
May 04,2021: Lineage Cell Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
Apr 26,2021: Lineage to Present at the B. Riley Securities’ Neuroscience Conference on April 28, 2021
Apr 22,2021: Lineage Announces Appointment of Dr. Dipti Amin to Its Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Lineage Cell Therapeutics Inc - Key Facts
Lineage Cell Therapeutics Inc - Key Employees
Lineage Cell Therapeutics Inc - Key Employee Biographies
Lineage Cell Therapeutics Inc - Major Products and Services
Lineage Cell Therapeutics Inc - History
Lineage Cell Therapeutics Inc - Company Statement
Lineage Cell Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Lineage Cell Therapeutics Inc - Business Description
Product Category: Grant revenue
Performance
Product Category: Royalties from product sales and license fees
Performance
Geographical Segment: Foreign
Performance
Geographical Segment: United States
Performance
R&D Overview
Lineage Cell Therapeutics Inc - Corporate Strategy
Lineage Cell Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Lineage Cell Therapeutics Inc - Strengths
Lineage Cell Therapeutics Inc - Weaknesses
Lineage Cell Therapeutics Inc - Opportunities
Lineage Cell Therapeutics Inc - Threats
Lineage Cell Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Lineage Cell Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Lineage Cell Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Lineage Cell Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 16, 2021: Lineage Cell Therapeutics Announces Kevin L. Cook to Join as Chief Financial Officer
Jun 15, 2021: Lineage Cell Therapeutics to Present at Raymond James 2021 Human Health Innovation Conference on June 22, 2021
May 04, 2021: Lineage Cell Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
Apr 26, 2021: Lineage to Present at the B. Riley Securities’ Neuroscience Conference on April 28, 2021
Apr 22, 2021: Lineage Announces Appointment of Dr. Dipti Amin to Its Board of Directors
Mar 11, 2021: Lineage Cell Therapeutics reports fourth quarter and full year 2020 financial results and provides business update
Mar 01, 2021: Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 11, 2021
Feb 23, 2021: Lineage to Present at the Raymond James 42nd Annual Institutional Investors Conference on March 1, 2021 and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021
Jan 21, 2021: Lineage posts series of webinars highlighting recent progress with its three clinical-stage allogeneic cell transplant programs
Jan 20, 2021: Lineage Cell Therapeutics announces change to executive team

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Lineage Cell Therapeutics Inc, Key Facts
Lineage Cell Therapeutics Inc, Key Employees
Lineage Cell Therapeutics Inc, Key Employee Biographies
Lineage Cell Therapeutics Inc, Major Products and Services
Lineage Cell Therapeutics Inc, History
Lineage Cell Therapeutics Inc, Subsidiaries
Lineage Cell Therapeutics Inc, Key Competitors
Lineage Cell Therapeutics Inc, Ratios based on current share price
Lineage Cell Therapeutics Inc, Annual Ratios
Lineage Cell Therapeutics Inc, Annual Ratios (Cont...1)
Lineage Cell Therapeutics Inc, Annual Ratios (Cont...2)
Lineage Cell Therapeutics Inc, Interim Ratios
Lineage Cell Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Lineage Cell Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Lineage Cell Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Lineage Cell Therapeutics Inc, Performance Chart (2016 - 2020)
Lineage Cell Therapeutics Inc, Ratio Charts
Lineage Cell Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Lineage Cell Therapeutics Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021